Our partner, U of N also shared their perspective on the launch of TherageniX, a spin-out company – TherageniX to deliver gene therapy as part of bone repair surgery. The innovative approach aims to enhance the healing process by introducing genes that promote bone regeneration. TherageniX establishment signifies a significant step towards translating research findings into practical applications, offering potential advancements in the field of orthopedic surgery and improved outcomes for patients undergoing bone repair procedures.
